Drug discovery and development in the age of molecular medicine

Clinical Pharmacology and Therapeutics

Volumn 82, Issue 4, 2007, Pages 363-366

  Vallance, P ^a   Levick, M ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; DNA; TAXANE DERIVATIVE; TRASTUZUMAB;

BIOTECHNOLOGY; BREAST CANCER; CLINICAL ASSESSMENT; DRUG INDUSTRY; DRUG MECHANISM; DRUG RESEARCH; DRUG SAFETY; DRUG SCREENING; DRUG TARGETING; GENE EXPRESSION; GENETIC ASSOCIATION; GENOMICS; GENOTYPE; HEALTH STATUS; HUMAN; MEDICINE; MOLECULAR GENETICS; MOLECULAR THERAPY; PHARMACOGENOMICS; PRIORITY JOURNAL; REVIEW; SIGNAL NOISE RATIO;

ANIMALS; CLINICAL MEDICINE; DRUG DESIGN; DRUG INDUSTRY; FORECASTING; GENOMICS; GENOTYPE; HUMANS; MOLECULAR BIOLOGY; PATIENT SELECTION; PHARMACOGENETICS; PHARMACOKINETICS; PHARMACOLOGY, CLINICAL; PHENOTYPE; REPRODUCIBILITY OF RESULTS;

EID: 34548695439     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/sj.clpt.6100333     Document Type: Review

References (14)

1. Mirosevich, J. et al. Expression and role of Foxa proteins in prostate cancer. Prostate 66, 1013-1028 (2005).
2. Martin, M., Reidhaar-Olson, J.F. & Rondinone, C.M. Genetic association meets RNA interference: large-scale genomic screens for causation and mechanism of complex disease. Pharmacogenomics 8, 455-464 (2007).
3. Pastinen, T., Ge, B. & Hudson, T.J. Influence of human genome polymorphism on gene expression. Hum. Molec. Genet. 15, R9-R16 (2006).
4. Eckfeldt, C.E. et al. Functional analysis of human hematopoietic stem cell gene expression using zebrafish. PLoS Biol. 3, e254 (2005).
5. International HapMap Project 〈http://www.hapmap.org〉. Accessed 1 July 2007.
6. Lesko, L.J. Paving the critical path: how can clinical pharmacology help achieve the vision? Clin. Pharmacol. Ther. 81, 170-177 (2007).
7. Montemurro, F., Valabrega, G. & Aglietta, M. Lapatinib: a dual inhibitor of EGFR and HER2 tyrosine kinase activity. Expert Opin. Biol. Ther. 7, 257-268 (2007).
8. Hahn, K.K., Wolff, J.J. & Kolesar, J.M. Pharmacogenetics and irinotecan therapy. Am. J. Health Syst. Pharm. 63, 2211-2217 (2006).
9. Giacomini, K.M. et al. The Pharmacogenetics Research Network: from SNP discovery to clinical drug response. Clin. Pharmacol. Ther. 81, 328-345 (2007).
10. British Broadcasting Corporation. Moorfields hospital carries out world's first gene therapy operation to cure blindness. 〈http://www.bbc.co.uk/ pressoffice/pressreleases/stories/2007/05_may/01/moorfields.shtml〉 (1 May 2007). Accessed 1 July 2007.
11. Piquette-Miller, M. & Grant, D.M. The art and science of personalized medicine. Clin. Pharmacol. Ther. 81, 311-315 (2007).
12. Guttmacher, A.E. & Collins, F.S. Realizing the promise of genomics in biomedical research. JAMA 294, 1399-1402 (2005).
13. National Cancer Institute and National Human Genome Research Institute. The Cancer Genome Atlas 〈http://cancergenome.nih.gov/index.asp〉. Accessed 1 July 2007.
14. Food and Drug Administration. Guidance for Industry: Pharmacogenomic Data Submissions 〈http://www.FDA.gov/cber/gdlns/pharmdtasub.htm〉 (March 2005). Accessed 1 July 2007.